Iovance Biotherapeutics, Inc. (LON: 0JDK)
London
· Delayed Price · Currency is GBP · Price in USD 5.86
-0.09 (-1.55%)
Jan 23, 2025, 2:44 PM BST
Iovance Biotherapeutics Market Cap
Iovance Biotherapeutics has a market cap or net worth of 1.48 billion as of January 23, 2025. Its market cap has decreased by -12.89% in one year.
Market Cap
1.48B
Enterprise Value
1.22B
Revenue
67.79M
Ranking
n/a
PE Ratio
n/a
Stock Price
5.86
Market Cap Chart
Since May 26, 2010, Iovance Biotherapeutics's market cap has increased from 62.39M to 1.48B, an increase of 2,275.98%. That is a compound annual growth rate of 24.10%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 169.60B |
| GSK plc | 55.25B |
| Haleon | 33.80B |
| Smith & Nephew | 8.96B |
| ConvaTec Group | 4.95B |
| Hikma Pharmaceuticals | 4.62B |
| HUTCHMED (China) | 2.00B |
| Oxford Nanopore Technologies | 1.37B |